e.g. mhealth
Search Results (1 to 10 of 62 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 30 JMIR Research Protocols
- 15 Journal of Medical Internet Research
- 3 JMIR Cancer
- 3 JMIR Formative Research
- 3 JMIR Mental Health
- 2 JMIR Aging
- 2 JMIR Biomedical Engineering
- 1 Interactive Journal of Medical Research
- 1 JMIR Neurotechnology
- 1 JMIR Public Health and Surveillance
- 1 JMIR Serious Games
- 0 Medicine 2.0
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR mHealth and uHealth
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Furthermore, biomarkers exhibit dynamic changes throughout treatment [13], and repeated sampling poses significant challenges for patient compliance.
In recent years, radiomics has enabled noninvasive characterization of tumor biology. Contrast-enhanced computed tomography (CT), a standard imaging modality for gastric cancer staging, captures spatial heterogeneity across entire tumors.
JMIR Cancer 2025;11:e67379
Download Citation: END BibTex RIS
To date, no studies have comprehensively measured minority stress (ie, discrimination, internalized homonegativity, concealment, and expected rejection [5]) in research examining SM biomarkers. Moreover, most research examines single markers of stress physiology. Next, the majority of research is cross-sectional. Thus, there is a need to fully explore the impact of minority stressors on a comprehensive measure of stress physiology dysregulation using longitudinal methods.
JMIR Res Protoc 2025;14:e73070
Download Citation: END BibTex RIS
The care of patients with non–small cell lung cancer (NSCLC) has changed dramatically since the early 2010s, from a chemotherapy-based approach that was tailored only to the disease histology (squamous or nonsquamous tumors) to becoming a disease with multiple actionable biomarkers that can identify targeted therapies associated with superior outcomes based on individual patient genomic characteristics [1,2].
JMIR Cancer 2025;11:e64399
Download Citation: END BibTex RIS
This suggests that clinicians should assess Ig AN holistically, not just focusing on the renal biomarkers.
To assess Ig AN’s prognosis, several stratification models have emerged, with the International Immunoglobulin A Nephropathy Prediction Tool (IIg AN-PT) by Barbour et al [12] being the most widely accepted.
J Med Internet Res 2025;27:e65563
Download Citation: END BibTex RIS
The LASSI-L has also differentiated between persons who are amyloid positive versus amyloid negative on the basis of other AD biomarkers such as plasma p-tau 181 [19] as well as plasma AB42/AB40 ratios using mass spectrometry.
A critical pragmatic factor associated with the LASSI-L is its cross-cultural sensitivity. Spanish and English versions of the test are equivalently valid [20-22] and have shown both multilingual and cross-cultural validity.
JMIR Ment Health 2025;12:e64716
Download Citation: END BibTex RIS
Exploring Molecular Genetics Research on Obesity in Malaysia: Protocol for a Scoping Review
However, only 12.3% of studies used experimental methods to investigate potential biomarkers, with genetic studies receiving minimal attention [19]. Moreover, the lack of a systematic compilation of existing research hampers efforts to effectively build upon previous work, exacerbating the challenge of designing new studies to address the research gap.
JMIR Res Protoc 2024;13:e60838
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Biomarkers could help detect individuals at risk of AD before symptoms occur. Cerebrospinal fluid (CSF) testing is considered the most reliable marker of progression of AD. Brain neuroimaging like computerized tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET), blood tests, and genetic testing are attracting increasing attention as important markers of this pathology [1,9,10]. CSF biomarkers such as β-amyloid 42 and tau and phosphor tau are key indicators of AD [11].
JMIR Aging 2024;7:e59370
Download Citation: END BibTex RIS
The identification of serum and urine biomarkers linked to RC is essential in order to characterize the kinetics of RC onset and predict the toxic effects of irradiation. This clinical trial thus aims to combine patient-related outcomes on adverse events and Qo L following radiotherapy, with an analysis of serum and urinary biomarkers that may be predictive of toxicity.
JMIR Cancer 2024;10:e48225
Download Citation: END BibTex RIS
Digital biomarkers offer a host of advantages for measuring our health over traditional assessment approaches that are typically confined to clinical settings, including decentralization, scalability, sampling frequency and real-time measurement, and affordability. However, significant challenges remain with implementing digital biomarkers.
Digital biomarkers developed from sensor data can help with prevention and early intervention to better diagnose and manage disease.
JMIR Ment Health 2024;11:e51259
Download Citation: END BibTex RIS